In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Cumulus Oncology with a team including Colin McCall (Picture – Life Science & Health Care)....
Cumulus Oncology and leadXpro’s Collaboration on GPR68-Targeting Cancer Therapeutics
Healx’s $47m Series C Funding Round
In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Healx with a team including Ross McNaughton (Picture – Corporate M&A), Colin McCall (IP&IT). Healx,...
Essential Pharma’s Acquisition of European Rights to Colobreathe
In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Essential Pharma with a team including Suzy Davis (Picture – Corporate M&A), Colin McCall (IP&IT),...
AlveoGene’s Spinout and Seed Investment
In UK Taylor Wessing, advised on the matter. Taylor Wessing advised AlveoGene with a team including Colin McCall (Picture – Corporate M&A), Ross McNaughton (Corporate M&A),...
Apollo Therapeutics’ $226.5m Series C Financing
In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Apollo Therapeutics with a team including Andrew Edge (Picture – Corporate M&A), Howard Palmer (Corporate...
ENOUGH’s €40 Million Financing Round From World Fund and CPT Capital
In UK Taylor Wessing, advised on the matter. Ashurst advised CPT Capital with a team including Taylor Wessing advised WF World Fund Management GmbH with a...
Upperton Pharma Solutions’ Investment From Inflexion
In UK Taylor Wessing, advised on the matter. Taylor Wessing advised Inflexion Private Equity with a team including Sian Skelton (Commercial Law), Jonny Bethell (Corporate M&A),...
Carlyle and PAI Partners’ Acquisition of Theramex
In UK Allen & Overy, Latham & Watkins, Linklaters, Taylor Wessing, advised on the matter. Allen & Overy advised Carlyle Global Partners, PAI Partners with a...
Rutland Partners’ Investment in JSM Group
In UK Philip Lee, Taylor Wessing, advised on the matter. Philip Lee advised JSM Group with a team including Andrew Tzialli (Picture – Corporate M&A). Taylor...